Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review
Although recent advances in novel treatment approaches and therapeutics have Arm Chair (set of 4) shifted the treatment landscape of multiple myeloma, it remains an incurable plasma cell malignancy.Growing knowledge of the genome and expressed genomic information characterizing the biologic behavior of multiple myeloma continues to accumulate.Howev